Corbus Pharmaceuticals Holdings (CRBP) FCF Margin Growth (1y) (2016 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) FCF Margin Growth (1y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 309,972.00 |
| Jun 30, 2021 | -353,839.00 |
| Mar 31, 2021 | -177,385.00 |
| Dec 31, 2020 | -113,942.00 |
| Sep 30, 2020 | -151,331.00 |
| Jun 30, 2020 | -924,062.00 |
| Mar 31, 2020 | -213,623.00 |
| Dec 31, 2019 | 606,102.00 |
| Sep 30, 2019 | 11,481.00 |
| Jun 30, 2019 | 76,230.00 |
| Mar 31, 2019 | 76,521.00 |
| Sep 30, 2018 | -2,555.00 |
| Jun 30, 2018 | 81,973.00 |
| Mar 31, 2018 | 29,436.00 |
| Sep 30, 2017 | -40,759.00 |
| Jun 30, 2017 | -97,122.00 |
| Mar 31, 2017 | 13,454.00 |
| Sep 30, 2016 | 107,215.00 |
| Jun 30, 2016 | -67,217.00 |